Literature DB >> 21721024

Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.

Ezequiel Ridruejo, Raúl Adrover, Marcelo O Silva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21721024     DOI： 10.1002/hep.24498

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Response-guided treatment of cirrhotic chronic hepatitis B patients: multicenter prospective study.

Authors:  Er-Li Gu; Yi-Qi Yu; Jia-Li Wang; Yan-Yan Ji; Xiu-Yun Ma; Qing Xie; Hong-Ying Pan; Shan-Min Wu; Jun Li; Cheng-Wei Chen; Xiao-Wei Xu; Yue-Er Wang; Guang-Bi Yao; Hong Wang; Wen-Hong Zhang
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

2.  Potential resistant mutations within HBV reverse transcriptase sequences in nucleos(t)ide analogues-experienced patients with hepatitis B virus infection.

Authors:  Xiaoman Zhang; Xianli Chen; Meijuan Wei; Chunyu Zhang; Tao Xu; Liguan Liu; Zhengju Xu
Journal:  Sci Rep       Date:  2019-05-30       Impact factor: 4.379

3.  Coevolution analysis of amino-acids reveals diversified drug-resistance solutions in viral sequences: a case study of hepatitis B virus.

Authors:  Elin Teppa; Francesca Nadalin; Christophe Combet; Diego Javier Zea; Laurent David; Alessandra Carbone
Journal:  Virus Evol       Date:  2020-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.